Skip to main content
NIH funding notice RFA-DA-22-031

HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)

Closed on October 19, 2021.

Posted
July 6, 2021
Close date
October 19, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,125,723 in first-year total cost, median $1,648,561.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 IXR-Q (09)]7

Most frequent institutions

  1. BAYLOR COLLEGE OF MEDICINE1
  2. SALK INSTITUTE FOR BIOLOGICAL STUDIES1
  3. SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE1
  4. UNIVERSITY OF ARIZONA1
  5. UNIVERSITY OF COLORADO DENVER1
Competing awards under RFA-DA-22-031 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Brain-penetrant GPR88 agonists as novel therapeutics for opioid abuse1R01DA056828-01JACKSON, MICHAELKENNY, PAUL J.SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA$2,150,978ZDA1
2022Domain-specific inhibition of angiotensin-converting enzyme as a therapeutic strategy for opioid use disorders1R01DA056675-01MORE, SWATI SROTHWELL, PATRICKUNIVERSITY OF MINNESOTA, MN$1,771,799ZDA1
2022Ghrelin Deacylase as a Treatment for Opioid Polysubstance Abuse1R01DA056646-01ZHAN, CHANG-GUOZHENG, FANGUNIVERSITY OF KENTUCKY, KY$1,700,947ZDA1
2022Endocannabinoid Targeting for Opioid Induced Respiratory Depression1R01DA056608-01MILNES, TALLY MARIEVANDERAH, TODD WUNIVERSITY OF ARIZONA, AZ$1,648,561ZDA1
2022Transcriptomic single-cell profiling in breathing-specific parabrachial mu-opioid receptor neurons1R01DA056658-01HAN, SUNGSALK INSTITUTE FOR BIOLOGICAL STUDIES, CA$742,953ZDA1
2022Target Specificity of Tabernanthalog Treatment in Opioid Use Disorder1R01DA056660-01HEINSBROEK, JASPERPETERS, JAMIEUNIVERSITY OF COLORADO DENVER, CO$103,440ZDA1
2022Targeting Tiam1-mediated synaptic plasticity for the relief of opioid tolerance1R01DA056673-01LI, LINGYONGTOLIAS, KIMBERLY RBAYLOR COLLEGE OF MEDICINE, TX$7,045ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-22-031: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience